Skip to main content
Previous Poster Home Next

Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of Head and Neck- Biweekly Docetaxel, Cisplatin, 5-fluorouracil, Leucovorin (TPFL) versus Triweekly TPF: Response Assessment and Translation into Survival Benefit
07:30am - 03:35pm EST - April 5, 2024

  • Information
  • Resources
  • Play Recording

Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of Head and Neck- Biweekly Docetaxel, Cisplatin, 5-fluorouracil, Leucovorin (TPFL) versus Triweekly TPF: Response Assessment and Translation into Survival Benefit icon

Abstract: JNCCN23-0649 https://jnccn.org/view/journal...


Author(s):
  • Sreevalli Anantharamu, MBBS, MD, DM, MRCP UK(SCE), ECMO, Consultant Medical Oncologist, Sri Shankara Cancer Hospital and Research Centre

Tags: Clinical Oncology

Display Label Action
Nccn final march 2024 new.pdf Download Handout
AC24P67 - Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of Head and Neck- Biweekly Docetaxel, Cisplatin, 5-fluorouracil, Leucovorin (TPFL) versus Triweekly TPF: Response Assessment and Translation into Survival Benefit Download MP3